A meta-analysis shows that the values of cardiac troponin I (cTnI) were found to be significantly increased in COVID-19 patients with severe disease than in those without [standardized mean difference (SMD), 25.6 ng/L; 95% confidence interval (CI), 6.8–44.5 ng/L] (5). This evidence concerns the gene TNNI3 and COVID-19.